ConductScience.org, home

Trial · NCT01165385

Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors

NCT01165385, Phase 1, Completed, UNICANCER

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors. Trials, record NCT01165385. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01165385

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors
NCT number
NCT01165385
Status
Completed
Phases
Phase 1
Enrollment
35 participants, actual
Lead sponsor
UNICANCER
Conditions
Solid Tumors, Metastatic Cancer
Interventions
cisplatin, Pazopanib
First posted
2010-07-19
Last updated
2014-11-17

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDetermination of the Optimal Tolerated Regimen (OTR) based on the occurrence of Dose Limiting Toxicitiescycles 1 and 2
SecondaryObjective response - Overall Objective response rate - Clinical Benefit RateAt baseline and every 6 weeks.Anti-tumor activity of the pazopanib/cisplatin combination will be carried out by the determination of the objective response rate according to RECIST criteria version 1.1.
SecondaryTo characterize the pharmacokinetic (PK) profile of the combination pazopanib and cisplatinCycles 1 and 2The objective of the pharmacokinetics is to investigate the interactions between cisplatin IV and pazopanib

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
28261651DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01165385

GET https://conductscience.org/api/trials/v1/NCT01165385/registered